Robert K. Brooks

Robert brings 25 years of life science capital market and corporate counsel experience.He founded the Company, and has served as Chairman and Chief Executive. Prior to Aurora, Robert founded and served as Chief Executive Officer of Medvax Technologies, a clinical stage cancer immunotherapy company developing dendritic cell and peptide cancer vaccines. Robert has been corporate counsel to numerous life science companies. He received his B.S. in Biology (pre-medicine concentration) Cum Laude from the University of Massachusetts, and Juris Doctorate from the University of Miami Law School. He has held a Series 7 securities license.